Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Understanding the mechanism of the interaction of flaxseed and flaxseed oil with trastuzumab in the treatment of HER2-overexpressing breast tumours

FY 2010-11

Summary
Breast cancer is the most common form of cancer in Canadian women and in about 25% of cases a protein called HER2 is present at abnormally high levels. This cancer type is aggressive and very difficult to treat. Currently these patients are treated with a drug called Herceptin but it only works in about one quarter of patients and when it does this only lasts for one year. Flaxseed and its oil have been shown to help reduce breast tumour growth and flaxseed oil has been shown to improve the effect of Herceptin in reducing tumour growth. The goal of this research is to understand, at the molecular level, how flaxseed oil improves the effect of Herceptin and also to determine whether flaxseed is as effective as flaxseed oil. Mice with tumours similar to those of HER2 positive patients will be given Herceptin treatment alone or while fed diets rich in flaxseed or flaxseed oil. The tumour growth and the levels of important cancer protein and gene markers and other changes at the molecular level will be measured in the tumours to understand how the growth is being affected. This research is important because most breast cancer patients change their diets to include dietary supplements, including flaxseed and flaxseed oil, therefore it should be studied whether these food components affect, beneficially or adversely, Herceptin`s action. If these dietary compounds can in fact improve the drug`s action it could lead to a simple, inexpensive, complementary treatment that may help to ultimately save lives.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
217988
Name
Mason Julie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Understanding the mechanism of the interaction of flaxseed and flaxseed oil with trastuzumab in the treatment of HER2-overexpressing breast tumours
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Athymic Mouse; Breast Cancer; Dietary Supplements; Drug-Diet Interaction; Flaxseed; Flaxseed Oil; Her2; Nutrition; Trastuzumab; Xenograft
Abstract
Breast cancer is the most common form of cancer in Canadian women and in about 25% of cases a protein called HER2 is present at abnormally high levels. This cancer type is aggressive and very difficult to treat. Currently these patients are treated with a drug called Herceptin but it only works in about one quarter of patients and when it does this only lasts for one year. Flaxseed and its oil have been shown to help reduce breast tumour growth and flaxseed oil has been shown to improve the effect of Herceptin in reducing tumour growth. The goal of this research is to understand, at the molecular level, how flaxseed oil improves the effect of Herceptin and also to determine whether flaxseed is as effective as flaxseed oil. Mice with tumours similar to those of HER2 positive patients will be given Herceptin treatment alone or while fed diets rich in flaxseed or flaxseed oil. The tumour growth and the levels of important cancer protein and gene markers and other changes at the molecular level will be measured in the tumours to understand how the growth is being affected. This research is important because most breast cancer patients change their diets to include dietary supplements, including flaxseed and flaxseed oil, therefore it should be studied whether these food components affect, beneficially or adversely, Herceptin`s action. If these dietary compounds can in fact improve the drug`s action it could lead to a simple, inexpensive, complementary treatment that may help to ultimately save lives.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mason, Julie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2010-11) | Canada Spends